Palisade Bio (PALI) Return on Sales Growth (1y) (2012 - 2023)

Palisade Bio (PALI) Return on Sales Growth (1y) (2012 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Palisade Bio 985.76 -132.63 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 7,173.00
Jun 30, 2023 3,194.00
Mar 31, 2023 6,094.00
Dec 31, 2020 -452.00
Sep 30, 2020 128.00
Jun 30, 2020 -515.00
Mar 31, 2020 590.00
Dec 31, 2019 -136.00
Sep 30, 2019 -41.00
Jun 30, 2019 -236.00
Mar 31, 2019 -21.00
Dec 31, 2018 -705.00
Sep 30, 2018 202.00
Jun 30, 2018 1,789.00
Mar 31, 2018 795.00
Dec 31, 2017 640.00
Sep 30, 2017 1,028.00
Jun 30, 2017 -139.00
Mar 31, 2017 878.00
Dec 31, 2016 1,257.00